RGCC ChemoSNiP test reveals how genetic variations affect cancer development and response to treatments, enabling personalised anti-cancer care.
RGCC ChemoSNiP test reveals how genetic variations affect cancer development and response to treatments, enabling personalised anti-cancer care.
RGCC ChemoSNiP is an advanced and innovative test that uses pharmacokinetics technology to assess your body’s response to specific anti-cancer drugs. The test reveals how your body metabolizes and reacts to cancer drugs, enabling clinicians to tailor therapies for optimal outcomes. It equips you with personalized information to ensure the most effective and targeted treatment plan tailored to your individual needs.
The ChemoSNiP test evaluates how your body responds to the specific anti-cancer drug by analyzing SNPs. The test answers which chemotherapeutic drug works best for your cancer and which doesn’t.
The test applies to all types of cancers and not just limited to the following.
The first step towards personalized cancer care is scheduling an appointment with us.
Upon booking the appointment, you get a consultation with our RGCC experts to assess your cancer status.
We guide you through the process of selecting the most effective tests for your specific cancer.
We deliver precise results that guide treatment decisions and enhance outcomes.
“RGCC’s ChemoSNiP test guides my treatment decisions with precision. It helps me tailor chemotherapy regimens to each patient’s genetic profile, improving efficacy and minimizing side effects. It’s an essential tool in personalized cancer care.”
Our RGCC accredited experts are here to help you with their expertise and guide you in your fight against cancer.
We recommend ChemoSNiP before starting chemotherapy as it will help the clinician to under whether the patient is a rapid metaboliser, normal metaboliser, or poor metaboliser.
When used together with data from chemosensitivity testing, ChemoSNiP helps to narrow the selection to the most effective and least toxic therapeutic agent.
Our cutting edge diagnostics and personalised tests makes a meaningful difference in the fight against cancer.
Looking for the most effective drug for your targeted cancer care? RGCC ChemoSNiP test analyzes your blood sample to identify which drugs will be most effective in treating your cancer. By analyzing DNA variations, RGCC ChemoSNiP delivers impactful results, offering long-term relief by eliminating cancer.